JANX JANUX THERAPEUTICS INC
2026Q1 · CUSIP 47103J105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
189
Δ holders QoQ
+12
Breadth percentile
Top 25%
Whale holders
100
Δ whales
+6
Inst. holding value
$825M
New positions
46
Closed positions
34
Price momentum (1Q)
+6.2%
Put / Call
4/8
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q4 | Top 8% | -34.8% | -33.4% |
| 2024Q2 | Top 6% | +23.7% | -9.7% |
| 2024Q1 | Top 3% | -7.8% | +3.5% |
| 2021Q3 | Top 12% | -16.3% | -48.1% |
Options Sentiment
Put holders
4
QoQ: -2
Call holders
8
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.84
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+47.1%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)